Orgenesis Inc. completed an acquisition involving Broaden Bioscience and Technology Corp. for not to exceed $11,000,000 (closed 2024-07-10).
“the Company will pay Broaden an amount equal to the value of the Assets established by a third party valuation firm selected by the Company (the “Valuation”), not to exceed $11,000,000 (the “Consideration”), less a debt adjustment relating to the $10,767,298 owed to the Company by Broaden for work performed and invoiced between August 2022 and May 2023 (the”
Orgenesis Inc.
Orgenesis Inc. completed an acquisition involving Theracell Advanced Biotechnology S.A, Theracell Advanced Biotechnology LTD and IDNA Genomics Public Limited for $13,000,000 (closed 2024-07-12).
“in the Purchase Agreement. Pursuant to the Purchase Agreement, in consideration for the purchase of the Assets, the Company will pay Theracell an aggregate purchase price of $13,000,000 (the “Consideration”), which is equal to the value of the Assets established by a third-party valuation firm selected by the Company, less a debt adjustment in the amount of”
SDSTStardust Power Inc.
Stardust Power Inc. underwent a change of control involving Global Partner Acquisition Corp II (closed 2024-07-08).
“As a result of the completion of the Business Combination pursuant to the Business Combination Agreement, a change of control of GPAC II occurred.”
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. completed a disposition involving Merz Pharmaceuticals, LLC for $185.0 million (closed 2024-07-10).
“payment obligations thereunder, Merz Pharma GmbH & Co. KGaA. The Asset Purchase Agreement provides for the sale of substantially all of the Company’s assets to the Purchaser for $185.0 million, less certain deductions and adjustments as specified in the Asset Purchase Agreement (the “Asset Sale”). On April 1, 2024, the Company, together with certain of its subsidiaries”
FWFWFLYWHEEL ADVANCED TECHNOLOGY, INC.
FLYWHEEL ADVANCED TECHNOLOGY, INC. completed a disposition involving Mericorn Company Limited for HKD56,360,000 (closed 2024-07-05).
“(the “ Shares ”) of the Company, representing all of the issued and outstanding equity securities of the Company, to the Buyer. The aggregate purchase price of the Shares was HKD56,360,000 (the “ Purchase Price ”). The Buyer transferred to the Seller 9.38% of the total issued and outstanding equity of Elison (938 shares) in satisfaction of the Purchase Price.”
MBCMasterBrand, Inc.
MasterBrand, Inc. completed an acquisition involving Supreme Cabinetry Brands, Inc. (from GHK Capital Partners LP) for $520 million in cash (closed 2024-07-11).
“MasterBrand, Inc. (NYSE: MBC, the “Company,” or “MasterBrand”), through its subsidiary MasterBrand Cabinets LLC, today announced that it has completed its acquisition of Supreme Cabinetry Brands, Inc. (“Supreme”), a highly regarded cabinetry company, from GHK Capital Partners LP (“GHK”) for $520 million in cash.”
MBCMasterBrand, Inc.
MasterBrand, Inc. completed an acquisition involving Dura Investment Holdings LLC for $520 million in cash (closed 2024-07-10).
“company (“ Dura ”) pursuant to the Amended Merger Agreement (as defined below). Pursuant to the Amended Merger Agreement, MasterBrand LLC acquired Dura for a purchase price of $520 million in cash, subject to customary adjustments as set forth in the Amended Merger Agreement (the “ Merger Consideration ”), via a merger whereby Merger Sub (as defined below) merged”
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. completed a disposition involving Amylyx Pharmaceuticals, Inc. for $35.1 million (closed 2024-07-09).
“the Company’s rights, title and interests in, to and under those assets and interests used by the Company in the development, manufacture and commercialization of Avexitide for $35.1 million, plus the aggregate amount of determined cure costs and assumed liabilities. At a hearing held on June 26, 2024, the Bankruptcy Court approved the sale of the Company’s Avexitide”
Calumet Specialty Products Partners, L.P.
Calumet Specialty Products Partners, L.P. underwent a change of control involving New Calumet (closed 2024-07-10).
“On July 10, 2024 (the “Closing Date”), the Partnership completed the previously announced transactions contemplated by (i) the Partnership Restructuring Agreement, dated November 9, 2023 (as amended, the “Partnership Restructuring Agreement”), among the Partnership, the General Partner and the other parties thereto, including The Heritage Group (collectively, the “Sponsor Parties”), as amended by the First Amendment to the Restructuring Agreement, dated February 9, 2024, and (ii) the Conversion Agreement, dated February 9, 2024 (as amended, the “Conversion Agreement”), among the Partnership, the General Partner, Calumet, Inc. (“New Calumet”), Calumet Merger Sub I LLC (“Merger Sub I”), Calumet Merger Sub II LLC (“Merger Sub II”) and the Sponsor Parties, as amended by the First Amendment to the Conversion Agreement, dated April 17, 2024 (such transactions, the “Conversion”).”
CTGOContango Silver & Gold Inc.
Contango Silver & Gold Inc. completed an acquisition involving HighGold Mining Inc. for 0.019 shares of Contango common stock (closed 2024-07-10).
“(“Contango” or the “Company”) completed its acquisition of HighGold Mining Inc., a corporation existing under the laws of the Province of British Columbia (“HighGold”), pursuant to the previously announced Arrangement Agreement and the Plan of Arrangement attached thereto (the “Arrangement Agreement”), dated May 1, 2024, by and among the Company, Contango Mining Canada Inc., a corporation organized under the laws of British Columbia and a wholly owned subsidiary of the Company, and HighGold (the “HighGold Acquisition”).”
AMLXAmylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. completed an acquisition involving Eiger BioPharmaceuticals, Inc. for $35.1 million (closed 2024-07-09).
“the Company agreed to acquire substantially all of the Seller’s rights, title and interests in, to and under those assets and interests used by the Seller in the development, manufacture and commercialization of Avexitide for $35.1 million”
CLMTCalumet, Inc. /DE
Calumet, Inc. /DE completed an acquisition involving Calumet GP, LLC for 5.5 million shares of Common Stock and 2.0 million Warrants (closed 2024-07-10).
“Merger Sub I merged with and into the General Partner, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of the Company, and all outstanding equity interests of the General Partner were exchanged into the right to receive an aggregate of 5.5 million shares of Common Stock and 2.0 million Warrants (the “GP Merger”).”
CLMTCalumet, Inc. /DE
Calumet, Inc. /DE completed an acquisition involving Calumet Specialty Products Partners, L.P. (closed 2024-07-10).
“Merger Sub II merged with and into the Partnership, with the Partnership continuing as the surviving entity and a wholly owned subsidiary of the Company, and all of the common units representing limited partner interests in the Partnership (“Common Units”) were exchanged into the right to receive an equal number of shares of Common Stock (the “Partnership Merger”);”
CLMTCalumet, Inc. /DE
Calumet, Inc. /DE underwent a change of control involving Calumet Specialty Products Partners, L.P., Calumet GP, LLC, The Heritage Group (closed 2024-07-10).
“On July 10, 2024, the Company completed the previously announced transactions contemplated by the Conversion Agreement.”
OVERSEAS SHIPHOLDING GROUP INC
OVERSEAS SHIPHOLDING GROUP INC underwent a change of control involving Saltchuk Resources, Inc. for $8.50 per Share (closed 2024-07-10).
“of the Company’s Class A common stock, par value $0.01 per share (the “Shares”), other than the Shares owned by Saltchuk, Merger Sub or any of their respective affiliates, for $8.50 per Share (the “Offer Price”), without interest and subject to any applicable tax withholding, upon the terms and subject to the conditions set forth in the Offer to Purchase,”
National Western Life Group, Inc.
National Western Life Group, Inc. underwent a change of control involving S. USA Life Insurance Company, Inc. (SUSA), a company of the Prosperity Life Group for Total Merger Consideration is approximately $1.9 billion, with each share of Common Stock converted into the right to receive $500.00 per share in cash (closed 2024-07-09).
“time of the Merger (the “ Effective Time ”), each share of Common Stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive $500.00 per share, net in cash, without interest and less any amounts that are required to be deducted and withheld under applicable law (the “ Merger Consideration ”). Including the”
HBUVHubilu Venture Corp
Hubilu Venture Corp completed an acquisition involving Gula for $32,940 (closed 2024-07-02).
“July 2, 2024, Hubilu closed on the acquisition and revenue share Agreement with Gula. The acquisition was for investment of Thirty-Two Thousand, Nine Hundred and Forty Dollars ($32,940.00) into Gula for a Four (4%) percent Non-Diluted Ownership Interest (“NDOI”) in Gula. Also included are any and all assets and axillary products and companies that are owned,”
WestRock Co
WestRock Co underwent a change of control involving Smurfit WestRock plc for $5.00 in cash and one validly issued, fully paid and non-assessable ordinary share of Smurfit WestRock (closed 2024-07-05).
“Pursuant to the terms of the Transaction Agreement, on July 5, 2024, (i) Smurfit WestRock acquired Smurfit Kappa by means of a scheme of arrangement (the “Scheme”), and each issued ordinary share of Smurfit Kappa was exchanged for one ordinary share of Smurfit WestRock, as a result of which Smurfit Kappa became a wholly owned subsidiary of Smurfit WestRock, and (ii) following the implementation of the Scheme, Merger Sub merged with and into WestRock (the “Merger,” and together with the Scheme, the “Combination”), with WestRock surviving the Merger and becoming a wholly owned subsidiary (the “Surviving Corporation”) of Smurfit WestRock.”
ELANElanco Animal Health Inc
Elanco Animal Health Inc completed a disposition involving Intervet International B.V. for approximately $1.3 billion in cash (closed 2024-07-09).
“On July 9, 2024, Elanco, Buyer and their applicable affiliates consummated the Transaction. The purchase price was approximately $1.3 billion in cash, subject to customary post-closing adjustments set forth in the Purchase Agreement.”
AFCGAdvanced Flower Capital Inc.
Advanced Flower Capital Inc. completed a disposition (closed 2024-07-09).
“AFC Gamma completed the Spin-Off on July 9, 2024, through the Distribution to all holders of outstanding shares of the Company’s common stock as of the close of business on the Record Date.”
SUNSSunrise Realty Trust, Inc.
Sunrise Realty Trust, Inc. underwent a change of control involving AFC Gamma, Inc. (closed 2024-07-09).
“On July 9, 2024, AFC Gamma completed the Spin-Off of the Company to the stockholders of AFC Gamma.”
SUNSSunrise Realty Trust, Inc.
Sunrise Realty Trust, Inc. completed a disposition involving AFC Gamma, Inc. (closed 2024-07-09).
“Pursuant to the Separation and Distribution Agreement, AFC Gamma completed the Spin-Off on July 9, 2024, through the Distribution to all holders of outstanding shares of AFC Gamma common stock as of the close of business on the Record Date.”
SILVER STAR PROPERTIES REIT, INC
SILVER STAR PROPERTIES REIT, INC completed an acquisition involving unaffiliated financial institution for $60.25 million (closed 2024-07-01).
“On July 1, 2024, the Company, through 16 newly formed special purposes entities ("Borrowers") collectively as borrowers purchased 16 triple-net properties leased by Walgreens for $60.25 million ("Walgreens Purchase and Sale Agreement") from an unaffiliated financial institution.”
Virpax Pharmaceuticals, Inc.
Virpax Pharmaceuticals, Inc. underwent a change of control involving an institutional investor (closed 2024-07-05).
“Upon the closing of the Financing, the Investor acquired control of the Company by appointing a majority of the Company’s Board of Directors.”
MYPSPLAYSTUDIOS, Inc.
PLAYSTUDIOS, Inc. completed an acquisition involving Pixode Games Limited for $3.5 million paid at closing (closed 2024-07-01).
“Israel acquired substantially all of the assets of Pixode (the “Pixode Acquisition”). The Pixode Acquisition closed on July 1, 2024. The purchase price for the transaction was $3.5 million paid at closing (of which $100,000 was withheld to cover potential future indemnification claims), a potential additional $1.0 million payable on launch of the Game (as defined”
Blue World Acquisition Corp
Blue World Acquisition Corp underwent a change of control involving TOYO Co., Ltd (closed 2024-07-01).
“On July 1, 2024 (the "Closing Date"), Blue World Acquisition Corporation, a Cayman Islands exempted company ("BWAQ"), consummated the previously announced business combination pursuant to the Agreement and Plan of Merger, dated as of August 10, 2023”
SWSmurfit Westrock plc
Smurfit Westrock plc completed an acquisition involving WestRock Company for one Smurfit WestRock Share and $5.00 in cash per WestRock share (closed 2024-07-05).
“each share of common stock, par value $0.01 per share, of WestRock (the “ WestRock Common Stock ”), other than shares of WestRock Common Stock issued and outstanding immediately prior to the effective time of the Merger and held by a holder of record who did not vote in favor of the approval and adoption of the Transaction Agreement (or consent thereto in writing) and properly demanded appraisal of such shares, was converted into the right to receive one Smurfit WestRock Share and $5.00 in cash (the “ Merger Consideration ”).”
SWSmurfit Westrock plc
Smurfit Westrock plc completed an acquisition involving Smurfit Kappa Group plc for one ordinary share of Smurfit WestRock per Smurfit Kappa share (closed 2024-07-05).
“On July 5, 2024, pursuant to the Transaction Agreement, dated as of September 12, 2023 (the “ Transaction Agreement ”), among Smurfit WestRock plc (formerly Smurfit WestRock Limited and prior to that known as Cepheidway Limited, “ Smurfit WestRock ” or the “ Company ”), Smurfit Kappa Group plc (“ Smurfit Kappa ”), WestRock Company (“ WestRock ”) and Sun Merger Sub, LLC (“ Merger Sub ”), (i) Smurfit WestRock acquired Smurfit Kappa by means of a scheme of arrangement (the “ Scheme ”) under the Companies Act 2014 of Ireland (as amended) (the “ Smurfit Kappa Share Exchange ”), and (ii) Merger Sub merged with and into WestRock, with WestRock continuing as the surviving entity (the “ Merger ,” and together with the Smurfit Kappa Share Exchange, the “ Combination ”).”
EVCENTRAVISION COMMUNICATIONS CORP
ENTRAVISION COMMUNICATIONS CORP completed a disposition involving IMS Internet Media Services, Inc. for $16.4 million (closed 2024-06-28).
“the Company, Entravision Digital Holdings, LLC ("Seller") and IMS. Cash proceeds from the transaction, net of working capital and other adjustments, received at the closing were $16.4 million. Immediately after the closing, an amount equal to $6.5 million of the proceeds was paid by the Company to the parties who sold MediaDonuts Pte. Ltd. to Seller on July 1, 2021”
SILVER STAR PROPERTIES REIT, INC
SILVER STAR PROPERTIES REIT, INC completed an acquisition involving unknown (multiple sellers) for combined cost of $40.75 million (closed 2024-07-01).
“As of July 1, 2024, Silver Star has completed the acquisition of three self-storage properties at a combined cost of $40.75 million, comprising 1,668 units within 161,164 square feet.”
SILVER STAR PROPERTIES REIT, INC
SILVER STAR PROPERTIES REIT, INC completed an acquisition involving Walgreens (seller unknown, presumably the counterparty is Walgreen Co. or its affiliate) for $60.25 million which was 100% financed (closed 2024-07-01).
“on July 1, 2024, the Company completed the acquisition of sixteen (16) triple-net properties leased by Walgreens for $60.25 million which was 100% financed.”
SILVER STAR PROPERTIES REIT, INC
SILVER STAR PROPERTIES REIT, INC completed a disposition involving JAHCO Richardson Heights LLC for $40.5 million in cash, subject to customary pro-rations and adjustments (closed 2024-06-28).
“On June 28, 2024, Silver Star Properties REIT, Inc. (the "Company"), completed the sale of its Richardson Heights property located in Richardson, Texas for a sales price of $40.5 million in cash, subject to customary pro-rations and adjustments. The property was sold to JAHCO Richardson Heights LLC, an unrelated third-party.”
WNHKWinning Catering Group, Inc.
Winning Catering Group, Inc. completed a disposition involving CCM Black Oak Ltd. for $3.8 million (closed 2024-07-01).
“a community enhancement fee for each lot sold. The aggregate purchase price and community enhancement fees, minus certain expenses, equaled a combined total of approximately $3.8 million. The sale of the lots closed on July 1, 2024. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be”
DecisionPoint Systems, Inc.
DecisionPoint Systems, Inc. underwent a change of control involving Barcoding Derby Buyer, Inc. (closed 2024-07-05).
“On July 5, 2024 (the "Closing Date"), Derby Merger Sub, Inc. ("MergerCo"), a Delaware corporation and wholly owned subsidiary of Barcoding Derby Buyer, Inc., a Delaware corporation ("Parent"), merged with and into DecisionPoint Systems, Inc., a Delaware corporation (the "Company"), with the Company continuing as the surviving corporation (the "Merger"), pursuant to the previously announced Agreement and Plan of Merger, dated April 30, 2024 (as it may be amended from time to time, the "Merger Agreement"), by and among the Company, MergerCo and Parent. As a result of the Merger, the Company became a wholly owned subsidiary of Parent.”
NODKNI Holdings, Inc.
NI Holdings, Inc. completed a disposition involving Scott Insurance Holdings, LLC for $10.5 million (closed 2024-06-30).
“On June 30, 2024 (“Closing Date”), the Company completed the previously announced sale of Westminster to Scott Insurance Holdings for a cash purchase price of $10.5 million”
VSTDVestand Inc.
Vestand Inc. completed an acquisition involving Mr. Jiyuck Hwang for $1,800,000 in cash, a promissory note in the principal amount of $600,000 and a convertible note having a principal amount of $1,200,000 (closed 2024-06-12).
“or substantially all of the assets of the following three restaurant entities owned by the Seller: Jjanga, HJH and Aku (the “Acquisition”). The Company agreed to pay the Seller $1,800,000 in cash, a promissory note in the principal amount of $600,000 (the “Promissory Note”) and a convertible note having a principal amount of $1,200,000 which shall be convertible”
RIMEAlgorhythm Holdings, Inc.
Algorhythm Holdings, Inc. completed an acquisition involving SemiCab, Inc. for 641,806 shares of its common stock, par value $0.01 (closed 2024-07-03).
“he “Buyer”), SemiCab, Inc., a Delaware corporation (“SemiCab” or the “Seller”), Ajesh Kapoor and”
HBUVHubilu Venture Corp
Hubilu Venture Corp completed an acquisition involving David A., Victor A., Edmund A., and Paul A. Garcia for $670,000 (closed 2024-06-27).
“David A., Victor A., Edmund A., and Paul A. Garcia (“Property Sellers”) to acquire real property located at 1460 North Eastern Avenue in Los Angeles. The acquisition for $670,000 closed on June 27, 2024. The foregoing description of the acquisition of the Eastern Agreement and the transaction contemplated thereby contained herein is qualified in its”
MBIOMUSTANG BIO, INC.
MUSTANG BIO, INC. completed an acquisition involving uBriGene (Boston) Biosciences, Inc. for $1,395,138 (closed 2024-06-27).
“pursuant to the NSA with CFIUS. As consideration for the Repurchase Transaction, the Company has agreed to pay to uBriGene a total purchase price (the “Purchase Price”) of $1,395,138, consisting of (i) an upfront payment of $100,000 due within five (5) business days of the Effective Date and a (ii) subsequent amount of $1,295,138 due on the date that is twelve”
VTRSViatris Inc
Viatris Inc completed a disposition involving Cooper Consumer Health SAS and certain of its affiliates for up to €1,950.0 million in cash (closed 2024-07-03).
“On July 3, 2024, Viatris Inc., a Delaware corporation (“ Viatris ” or the “ Company ”), closed the previously announced transaction with Cooper Consumer Health SAS, a French corporation (“ Cooper Consumer Health ”), involving the divestiture by Viatris of substantially all of Viatris’ over-the-counter products business (the “ Business ”) and related assets and liabilities (the “ Transaction ”), to Cooper Consumer Health and certain of its affiliates (collectively, the “ Buyer Parties ”), in exchange for consideration from the Buyer Parties of up to €1,950.0 million in cash on a cash-free, debt-free basis, consisting of (a) €1,850.0 million in cash consideration at closing, subject to certain adjustments as set forth in the Transaction Agreement (defined below), including for net indebtedness and net working capital, and (b) up to €100.0 million in contingent additional cash consideration, which shall be payable by the Buyer Parties to Viatris following closing if the shareholders of th”
STAR EQUITY HOLDINGS, INC.
STAR EQUITY HOLDINGS, INC. completed a disposition involving Timber Properties, LLC for $3.0 million plus closing costs (closed 2024-06-28).
“Timber Properties, LLC (“Timber Properties”), an affiliate of the Seller, sold to 106 Bremer, LLC, a wholly-owned subsidiary of the Company (“106 Bremer”), all of Timber Properties’ Owned Real Property (as defined in the Asset Purchase Agreement) pursuant to a Real Estate Sales Agreement for $3.0 million plus closing costs.”
THFFFIRST FINANCIAL CORP /IN/
FIRST FINANCIAL CORP /IN/ completed an acquisition involving SimplyBank for $718.38 per share in cash (closed 2024-07-01).
“other than dissenting shares, each share of SimplyBank Common Stock issued and outstanding immediately prior to the Effective Time, was converted into the right to receive $718.38 per share in cash. The aggregate value of the transaction was approximately $73.4 million. The foregoing summary of the Merger Agreement is not complete and is qualified in its”
EVERBRIDGE, INC.
EVERBRIDGE, INC. completed an acquisition involving Thoma Bravo Discover Fund IV, L.P., an investment fund managed by Thoma Bravo, L.P. for $35.00 in cash (closed 2024-07-02).
“series of Convertible Notes in effect on the applicable conversion date (subject to any adjustments pursuant to the relevant Convertible Notes Indenture) multiplied by $35.00 (i.e., the Per Share Price (as defined below)). The consummation of the Merger constitutes a Merger Event, a Fundamental Change and a Make-Whole Fundamental Change (each as”
HBUVHubilu Venture Corp
Hubilu Venture Corp completed an acquisition involving David A., Victor A., Edmund A., and Paul A. Garcia for $670,000 (closed 2024-06-27).
“David A., Victor A., Edmund A., and Paul A. Garcia (“Property Sellers”) to acquire real property located at 1460 North Eastern Avenue in Los Angeles. The acquisition for $670,000 closed on June 27, 2024. The foregoing description of the acquisition of the Eastern Agreement and the transaction contemplated thereby contained herein is qualified in its”
HBUVHubilu Venture Corp
Hubilu Venture Corp completed an acquisition involving Andrea Abler for $710,000 (closed 2024-06-27).
“agreement (“the 35 th Street Agreement”) with Andrea Abler (“Property Seller”) to acquire real property located at 1457 W. 35 th Street in Los Angeles. The acquisition for $710,000 closed on June 27, 2024. The foregoing description of the acquisition of the 35 th Street Agreement and the transaction contemplated thereby contained herein is qualified in”
Odyssey Semiconductor Technologies, Inc.
Odyssey Semiconductor Technologies, Inc. completed a disposition involving Power Integration Inc. (closed 2024-07-01).
“On July 1, 2024, pursuant to the Asset Purchase Agreement and subject to the satisfaction or waiver of certain conditions and limitation provided therein, the Seller Parties and Power Integration closed the sales, transfer and assignment of substantially all of the Company’s assets (the “Asset Sale”) to Power Integration.”
Akili, Inc.
Akili, Inc. underwent a change of control involving Virtual Therapeutics Corporation (Parent) and Alpha Merger Sub, Inc. (Purchaser) for $0.4340 per share (closed 2024-07-02).
“offer to purchase all of the C ompany’s outstanding shares of common stock, par value $0.0001 per share (the “ Common Stock ”), for a price per share of the Common Stock of $0.4340 (the “ Offer Price ”), payable subject to any applicable tax withholding and without interest, all subject to and in accordance with the terms and conditions set forth in the”
Inrad Optics, Inc.
Inrad Optics, Inc. completed an acquisition involving Inrad Optics, Inc. for approximately $19 million (closed 2024-07-02).
“Capital Partners, both of which are U.S.-based private equity firms. The aggregate cash consideration paid by Parent to Company stockholders in the Merger was approximately $19 million. The source of the funds for the consideration paid by Parent in the Merger was borrowings under a secured credit facility. --- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 4”
Inrad Optics, Inc.
Inrad Optics, Inc. underwent a change of control involving Luxium Solutions, LLC for $1.10 in cash (closed 2024-07-02).
“the Company (the “Common Stock”) issued and outstanding (other than Cancelled Shares (as defined in the Merger Agreement)) was converted automatically into the right to receive $1.10 in cash, without interest (the “Merger Consideration”). In connection with the Merger Agreement, on April 8, 2024, the Company entered into a Conversion and Cancellation Agreement”
ENCORE WIRE CORP
ENCORE WIRE CORP underwent a change of control involving Prysmian S.p.A. for $290.00 in cash (closed 2024-07-02).
“prior to the Effective Time (other than certain excluded shares (as specified in the Merger Agreement)) were converted automatically into the right to receive, without interest, $290.00 in cash (the “ Merger Consideration ”), subject to any required tax withholding. Immediately prior to the Effective Time, each Company equity award granted prior to the date of”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.